Mice with adenine phosphoribosyltransferase deficiency develop fatal 2,8-dihydroxyadenine lithiasis

Human Gene Therapy

Volumn 7, Issue 13, 1996, Pages 1491-1502

  Redhead, Nicola J ^b   Selfridge, Jim ^b   Wu, Chao Liang ^a   Melton, David W ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,8 DIHYDROXYADENINE; ADENINE PHOSPHORIBOSYLTRANSFERASE; ALLOPURINOL; ANTIUROLITHIASIS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENZYME DEFICIENCY; GENE TARGETING; KIDNEY TUBULE; LESCH NYHAN SYNDROME; MORPHOLOGY; MOUSE; NEPHROLITHIASIS; NONHUMAN; PHENOTYPE; PURINE METABOLISM; STONE FORMATION; SYMPTOM; URINE LEVEL;

EID: 0029763372     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.13-1491     Document Type: Article

References (30)

1. - SCID: Initial trial results after 4 years. Science 270, 475-480.
2. DUSH, M.K., SIKELA, J.M., KHAN, S.A., TISCHFIELD, J.A., and STAMBROOK, P.J. (1985). Nucleotide sequence and organisation of the mouse adenine phosphoribosyltransferase gene: Presence of a coding region common to animal and bacterial phosphoribosyltransferases that has a variable intron/exon arrangement. Proc. Natl. Acad. Sci. USA 82, 2731-2735.
3. DUSH, M.K., TISCHFIELD, J.A., KHAN, S.A., FELICIANO, E., SIKELA, J.M., KOZAK, C.A., and STAMBROOK, P.J. (1986). An unusual phosphoribosyltransferase pseudogene is syntenic with its functional gene and is flanked by highly polymorphic DNAs. Mol. Cell. Biol. 6, 4161-4167.
4. FINGER, S., HEAVENS, R.P., SIRINATHSINGHJI, D.J., KUEHN, M.R., and DUNNETT, S.B. (1988). Behavioral and neurochemical evaluation of a transgenic mouse model of Lesch-Nyhan syndrome. J. Neurol. Sci. 86, 203-213.
5. FRIEDMANN, T. (1992). A brief history of gene therapy. Nature Genet. 2, 93-98.
6. HENDERSON, J.F., ZOMBOR, G., JOHNSON, M.M., and SMITH, C.M. (1983). Variation in erythrocyte purine metabolism among mouse strains. Comp. Biochem. Physiol. 76B, 419-422.
7. HERSHFIELD, M.S., and MITCHELL, B.S. (1995). Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle. eds. (McGraw-Hill, Inc.) pp. 1725-1768.
8. HOOPER, M., HARDY, K., HANDYSIDE, A., HUNTER, S., and MONK, M. (1987). HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonisation by cultured cells. Nature 326, 292-295.
9. JINNAH, H.A., GAGE, F.H., and FRIEDMANN, T. (1991). Amphetamine-induced behavioral phenotype in a hypoxanthine-guanine phosphoribosyltransferase-deficient mouse model of Lesch-Nyhan syndrome. Behav. Neurosci. 105, 1004-1012.
10. JINNAH, H.A., WOJCIK, B.E., HUNT, M., NARANG, N., LEE, K.Y., GOLDSTEIN, M., WAMSLEY, J.K., LANGLAIS, P.J., and FRIEDMANN, T. (1994). Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J. Neurosci. 14, 1164-1175.
11. KUEHN, M.R., ROBERTSON, E.R., and EVANS, M.J. (1987). A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326, 295-298.
12. LAKE, C.R., and ZIEGLER, M.G. (1977). Lesch-Nyhan syndrome: low dopamine-β-hydroxylase activity and diminished sympathetic response to stress and posture. Science 196, 905-906.
13. LLOYD, K.G., HORNYKIEWICZ, O., DAVIDSON, L., SHANNAK, K., FARLEY, I., GOLDSTEIN, M., SHIBUYA, M., KELLEY, W.N., and FOX, I.H. (1981). Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. New Engl. J. Med. 305, 1106-1111.
14. MANSOUR, S.L., THOMAS, K.R., and CAPECCHI, M.R. (1988). Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to nonselectable genes. Nature 336, 348-352.
15. MELTON, D.W., McEWAN, C., McKIE, A.B., and REID, A.M. (1986). Expression of the mouse HPRT gene: deletional analysis of the promoter region of an X-chromosome linked housekeeping gene. Cell 44, 319-328.
16. MIGCHIELSEN, A.A.J., BREUER, M.L., VEN ROON, M.A., TE REIL, H., ZURCHER, C., OSSENDORP, F., TOUTAIN, S., HERSCHHELD, M.S., BERNS, A., and VALERIO, D. (1995). Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death. Nature Genet. 10, 279-287.
17. MILLER, S.A., DYKES, D.D., and POLESKY, H.F. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215.
18. MOORE, R.C., REDHEAD, N.J., SELFRIDGE, J., HOPE, J., MANSON, J.C., and MELTON, D.W. (1995). Double replacement gene targeting for the production of a series of mouse strains with different prion protein gene alterations. Bio/Technology 13, 999-1004.
19. ROSSITER, B J.F., and CASKEY, C.T. (1995). Hypoxanthine-guanine phosphoribosyltransferase deficiency: Lesch-Nyhan syndrome and gout. In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle. eds. (McGraw-Hill, Inc.) pp. 1697-1706.
20. SABINA, R.L., and HOLMES, E.W. (1995). Myoadenylate deaminase deficiency. In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle. eds. (McGraw-Hill, Inc.) pp. 1769-1780.
21. SEEBURG, P.H. (1982). The human growth hormone family: Nucleotide sequences show recent divergence and predict a new polypeptide. DNA 1, 239-249.
22. SELFRIDGE, J., POW, A.M., McWHIR, J., MAGIN, T.M., and MELTON, D.W. (1992). Gene targeting using a mouse HPRT mini-gene/HPRT-deficient embryonic stem cell system: inactivation of the mouse ERCC-1 gene. Somat. Cell. Mol. Genet. 18, 325-336.
23. SIMMONDS, H.A., SAHOTA, A.S., and VAN ACKER, K.J. (1995a). Adenine phosphoribosyltransferase deficiency and 2,8-dihydroxyadenine lithiasis. In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle. eds. (McGraw-Hill, Inc.) pp. 1707-1724.
24. SIMMONDS, H.A., REITER, S., and NISHINO, T. (1995b). Hereditary xanthinuria. In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle. eds. (McGraw-Hill, Inc.) pp. 1781-1797.
25. TAGESSON, C., KALLBERG, M., KLINTENBERG, C., and STARKHAMMAR, H. (1995). Determination of urinary 8-hydroxydeoxyguanosine by automated coupled-column high performance liquid chromatography: A powerful technique for assaying in vivo oxidative DNA damage in cancer patients. Eur. J. Cancer 31A, 934-940.
26. THOMPSON, S., CLARKE, A.R., POW, A.M., HOOPER, M.L., and MELTON, D.W. (1989). Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic cells. Cell 56, 313-321.
27. VAN ACKER, K.J., SIMMONDS, H.A., POTTER, C.F., and CAMERON, J.S. (1977). Complete deficiency of adenine phosphoribosyltransferase: Report of a family. N. Engl. J. Med. 297, 127-132.
28. WAKAMIYA, M., BLACKBURN, M.R., JURECIC, R., McARTHUR, M.J., GESKE, R.S., CARTWRIGHT, J., MITANI, K., VAISHNAV, S., BELMONT, J.W., KELLEMS, R.E., FINEGOLD, M.J., MONTGOMERY, C.A., JR., BRADLEY, A., and CASKEY, C.T. (1995). Disruption of the adenosine deaminasc gene causes hepatocellular impairment and perinatal lethality in mice. Proc. Natl. Acad. Sci. USA 92, 3673-3677.
29. WU, C.-L., and MELTON, D.W. (1993). Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice. Nature Genet. 3, 235-240.
30. WU, X., WAKAMIYA, M., VAISHNAV, S., GESKE, R., MONTGOMERY, C., JR., JONES, P., BRADLEY, A., and CASKEY, C.T. (1994). Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc. Natl. Acad. Sci. USA 91, 742-746.